# Clinical Survey Study to Assess Physical Function and the Incidence of Hypoglycemia in Participants With Glycogen Storage Disease Type III

> **NCT05196165** · — · TERMINATED · sponsor: **Ultragenyx Pharmaceutical Inc** · enrollment: 14 (actual)

## Conditions studied

- Glycogen Storage Disease Type III

## Interventions

- **OTHER:** No Intervention

## Key facts

- **NCT ID:** NCT05196165
- **Lead sponsor:** Ultragenyx Pharmaceutical Inc
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2022-05-20
- **Primary completion:** 2023-03-02
- **Final completion:** 2023-03-02
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** Sponsor decision not related to safety concerns
- **Last updated:** 2023-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05196165

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05196165, "Clinical Survey Study to Assess Physical Function and the Incidence of Hypoglycemia in Participants With Glycogen Storage Disease Type III". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05196165. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*